Sign in
4

Changes in Ownership

Adicet Bio, Inc. Filed Acc 0001209191-23-046099

Options or other derivatives

  • Chief Technology Officer acquired 492,544 shares (grant or award)
  • Chief Technology Officer returned 342,600 shares (to the company)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Healey Don Chief Technology Officer 2023-08-14 Returned to the company · Stock Option (Right to Buy) −70,000 0 D
Healey Don Chief Technology Officer 2023-08-14 Grant or award · Stock Option (Right to Buy) +70,000 70,000 D
Healey Don Chief Technology Officer 2023-08-14 Returned to the company · Stock Option (Right to Buy) −30,400 0 D
Healey Don Chief Technology Officer 2023-08-14 Grant or award · Stock Option (Right to Buy) +30,400 30,400 D
Healey Don Chief Technology Officer 2023-08-14 Returned to the company · Stock Option (Right to Buy) −125,000 0 D
Healey Don Chief Technology Officer 2023-08-14 Grant or award · Stock Option (Right to Buy) +125,000 125,000 D
Healey Don Chief Technology Officer 2023-08-14 Returned to the company · Stock Option (Right to Buy) −117,200 0 D
Healey Don Chief Technology Officer 2023-08-14 Grant or award · Stock Option (Right to Buy) +117,200 117,200 D
Healey Don Chief Technology Officer 2023-08-14 Grant or award · Stock Option (Right to Buy) +149,944 149,944 D
Loading xslF345X05/doc4.xml…